Analysts expect Dianthus Therapeutics, Inc. /DE/ to report revenue of 285,074.37 for Q2 26, against a range of 266,702.18 to 303,446.56. The most recent reported quarter, Q1 26, came in at 463,000.00, a 8.8% beat against the 425,714.16 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.86 M | 2.17 M | 1.32 M | 1.16 M | 193,000.00 | 396,000.00 | 284,000.00 | 463,000.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 362,441.86 | 736,337.73 | 970,370.37 | 803,820.63 | 990,201.70 | 642,001.28 | 604,013.88 | 467,287.28 | 303,446.56 | 323,034.49 | 318,026.37 | 375,024.14 | -1,009.60 | 134,042.69 | 64,353.41 | 4.25 M | |||||||||||
| Low Estimate | 336,625.30 | 676,667.91 | 878,658.53 | 718,307.47 | 827,586.04 | 570,801.28 | 530,321.76 | 384,141.04 | 266,702.18 | 264,405.61 | 260,929.19 | 331,428.92 | -1,132.74 | 117,308.95 | 55,822.71 | 3.86 M | |||||||||||
| Consensus Estimate | 349,533.58 | 706,502.82 | 924,514.45 | 761,064.05 | 908,893.87 | 606,401.28 | 567,167.82 | 425,714.16 | 285,074.37 | 293,720.05 | 289,477.78 | 353,226.53 | -1,071.17 | 125,675.82 | 60,088.06 | 4.06 M |
Analysts expect Dianthus Therapeutics, Inc. /DE/ to report earnings per share of -0.83 for Q2 26, against a range of -0.91 to -0.75. The most recent reported quarter, Q1 26, came in at -0.85, a 22.7% beat against the -1.10 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.51 | -0.74 | -0.81 | -0.82 | -0.88 | -0.97 | -1.43 | -0.85 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.47 | -0.52 | -0.80 | -0.85 | -0.77 | -0.76 | -0.99 | -1.00 | -0.75 | -0.93 | -1.00 | -1.03 | -0.93 | -1.11 | -1.25 | -1.11 | |||||||||||
| Low Estimate | -0.57 | -0.62 | -0.86 | -0.97 | -0.89 | -0.88 | -1.13 | -1.20 | -0.91 | -1.05 | -1.14 | -1.19 | -1.05 | -1.31 | -1.51 | -1.19 | |||||||||||
| Consensus Estimate | -0.52 | -0.57 | -0.83 | -0.91 | -0.83 | -0.82 | -1.06 | -1.10 | -0.83 | -0.99 | -1.07 | -1.11 | -0.99 | -1.21 | -1.38 | -1.15 |